VRC01 provides sterilizing protection to non human primates from mucosal SHIV challenges

被引：0
|
作者：
Pegu, Amarendra [1 ]
Yang, Zhi-yong [1 ]
Chen, Xuejen [1 ]
Todd, John-Paul [1 ]
McKee, Krisha [1 ]
Rao, Srinivas [1 ]
Mascola, John [1 ]
Nabel, Gary [1 ]
机构：
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF IMMUNOLOGY | 2011年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
155.11
引用
收藏
页数：2
相关论文
共 23 条
  • [21] STRONTIUM-90 BIOKINETICS FROM SIMULATEDWOUND INTAKES IN NON-HUMAN PRIMATES COMPARED WITH COMBINED MODEL PREDICTIONS FROM NATIONAL COUNCIL ON RADIATION PROTECTION AND MEASUREMENTS REPORT 156 AND INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION PUBLICATION 67
    Allen, Mark B.
    Brey, Richard R.
    Gesell, Thomas
    Derryberry, Dewayne
    Poudel, Deepesh
    HEALTH PHYSICS, 2016, 110 (01): : 11 - 28
  • [22] Recombinant Ebolavirus antigens from insect cells are potent immunogens inducing cellular and humoral immunity in rodents and non-human primates and provide protection against virus challenge
    Lieberman, Michael
    Lehrer, Axel
    Humphreys, Tom
    Johns, Lisa
    Wong, Teri-Ann
    Olinger, Gene
    Dye, John
    Carrion, Ricardo
    Patterson, Jean
    Marzi, Andrea
    Feldmann, Heinz
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [23] Comparable Protection of Human T-Cells from High Dose Challenges of HIV-1 Using Gutless and Non-Gutless rSV40 Vectors Carrying Anti-Integrase scFv: Implications for Gene Therapy
    Marusich, Elena I.
    Strayer, David S.
    MOLECULAR THERAPY, 2006, 13 : S59 - S60
123